Woodbridge, CT, United States of America

Michael Brines

USPTO Granted Patents = 22 

 

 

Average Co-Inventor Count = 2.8

ph-index = 5

Forward Citations = 192(Granted Patents)


Company Filing History:


Years Active: 2003-2020

Loading Chart...
Loading Chart...
Loading Chart...
22 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Michael Brines

Introduction

Michael Brines, based in Woodbridge, CT, has made significant strides in the field of biomedical innovation. With a remarkable portfolio of 22 patents, his work primarily focuses on the development of tissue protective peptides aimed at preventing and treating diseases associated with tissue damage.

Latest Patents

Among his latest inventions, Brines has introduced a series of novel tissue protective peptides that boast a variety of applications in medicine. These peptides and their analogs exhibit tissue protective activities, offering promising solutions for preventing and treating various diseases and conditions associated with tissue damage. Notably, his inventions include peptides derived from or sharing consensus sequences with portions of cytokine receptor ligands, specifically Erythropoietin (EPO). These peptides are meticulously designed to avoid interference with the ligand's binding mechanism to the receptor complex, thus enhancing therapeutic efficacy.

The inventions encompass not only the peptides but also methods for utilizing these tissue protective peptides to treat diseases or enhance excitable tissue function. The innovations highlight the potential for new methodologies in treating conditions related to tissue damage, paving the way for advancements in biomedical interventions.

Career Highlights

Michael Brines has an impressive career that includes pivotal roles at reputable organizations. He has contributed significantly to the Kenneth S. Warren Institute, Inc. and Araim Pharmaceuticals, Inc., where he advanced his research and development of biomedical innovations. His dedication to pushing the boundaries of science has established him as a respected figure in the field.

Collaborations

Throughout his career, Brines has collaborated with esteemed professionals, including Anthony Cerami and Carla Cerami. These partnerships have not only enriched his research but have also fostered innovation within the industry, creating opportunities for breakthroughs in tissue protection and treatment methodologies.

Conclusion

Michael Brines exemplifies the spirit of innovation in the biomedical field. His extensive portfolio of patents reflects a commitment to enhancing healthcare through scientific discovery. As he continues to explore the potential of tissue protective peptides, his contributions are poised to make a lasting impact on the treatment of diseases associated with tissue damage.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…